JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB308101

Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Multiclonal EEF2/Elongation factor 2 phospho T56 antibody. Suitable for WB and reacts with Mouse, Human samples. Immunogen corresponding to Synthetic Peptide within Human EEF2 phospho T56.

View Alternative Names

EF2, EEF2, Elongation factor 2, EF-2

2 Images
Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (AB308101)
  • WB

Supplier Data

Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (AB308101)

Western blot analysis was performed on Whole cell extracts (30 µg lysate) of Jurkat (Lane 1), T98G (Lane 2), Hep G2 (Lane 3), 3T3-L1 (Lane 4), 3T3-L1 treated with Forskolin (100uM for 60 mins) (Lane 5), NIH/3T3 (Lane 6), NIH/3T3 treated with Forskolin (100uM for 60 mins) (Lane 7). The blots were probed with ab308101 and detected by chemiluminescence using Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1 : 4000 dilution. A 95 kDa band corresponding to EEF2 (phospho T56) was observed across the cell lines tested. Known quantity of protein samples were electrophoresed using a 4-12% Bis-Tris gel, electrophoresis system and pre-stained protein standard. Resolved proteins were then transferred onto a nitrocellulose membrane. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5% skimmed milk. Chemiluminescent detection was performed (ECL).

All lanes:

Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (ab308101) at 2.5 µg/mL

Lane 1:

Jurkat cell lysate at 30 µg

Lane 2:

T98G cell lysate at 30 µg

Lane 3:

HepG2 cell lysate at 30 µg

Lane 4:

3T3-L1 cell lysate at 30 µg

Lane 5:

Forskolin treated 3T3-L1 cell lysate at 30 µg

Lane 6:

NIH/3T3 cell lysate at 30 µg

Lane 7:

Forskolin treated NIH/3T3 cell lysate at 30 µg

Secondary

All lanes:

HRP conjugated Goat anti-Rabbit IgG (H+L) Secondary Antibody at 1/4000 dilution

Observed band size: 95 kDa

true

Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (AB308101)
  • WB

Supplier Data

Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (AB308101)

Western blot analysis was performed on Whole cell extracts (30 µg lysate) of NIH/3T3 (Lane 1) and NIH/3T3 treated with Forskolin (100uM for 60 mins) (Lane 2). The blots were probed with ab308101 and detected by chemiluminescence using Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1 : 4000 dilution. A 95 kDa band corresponding to EEF2 (phospho T56) was observed. Antibody specificity was demonstrated by competition with the EEF2 (phospho T56) peptide, which results in loss of signal. No competition was observed with the non-phospho peptide. Known quantity of protein samples were electrophoresed using a 4-12% Bis-Tris gel, electrophoresis system and pre-stained protein standard. Resolved proteins were then transferred onto a nitrocellulose membrane. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5% skimmed milk. Chemiluminescent detection was performed (ECL).

All lanes:

Western blot - Anti-EEF2/Elongation factor 2 (phospho T56) antibody [RP23040245] (ab308101) at 2.5 µg/mL

Lane 1:

untreated NIH/3T3 cell lysate at 30 µg

Lane 2:

Forskolin treated NIH/3T3 cell lysate at 30 µg

Lane 3:

EEF2 (phospho T56) phosphopeptide incubated NIH/3T3 cell lysate at 30 µg

Lane 4:

EEF2 (phospho T56) phosphopeptide incubated Forskolin treated NIH/3T3 cell lysate at 30 µg

Lane 5:

non-phosphopeptide incubated NIH/3T3 cell lysate at 30 µg

Lane 6:

Non-phosphopeptide treated Forskolin treated NIH/3T3 cell lysate at 30 µg

Secondary

All lanes:

Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution

Observed band size: 95 kDa

true

Key facts

Host species

Rabbit

Clonality

Multiclonal

Clone number

RP23040245

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human EEF2 phospho T56.

P13639

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2.5 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2.5 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:

  • - The sensitivity of polyclonal antibodies by recognising multiple epitopes
  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

View our range of recombinant multiclonal antibodies.

Properties and storage information

Form
Liquid
Storage buffer
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

EEF2 or elongation factor 2 is an important protein in the process of translation during protein synthesis. It is also known by the names EF-2 and EF2. This protein facilitates the translocation step where it moves tRNA and mRNA from the A-site to the P-site on the ribosome. EEF2 has a molecular weight of approximately 95 kDa. The protein is ubiquitously expressed in various tissues and cells due to its fundamental role in protein synthesis making it essential for cellular activities.
Biological function summary

EEF2 functions as part of a larger ribosomal complex. It has an important role in ensuring the accuracy and efficiency of elongation during the translation process. This process is energy-dependent with EEF2 requiring GTP to catalyze the movement along the mRNA strand. The protein must undergo reversible phosphorylation which directly affects its activity. This post-translational modification of EEF2 is a significant modulation point influencing the rate of protein synthesis.

Pathways

EEF2 plays an integral role in the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway EEF2 activity is regulated to control protein translation based on cellular energy status and nutrient availability. This pathway is important for cell growth and proliferation. EEF2 interacts with other proteins such as factor 2 and eEF2kinase which phosphorylates the protein thereby inhibiting its activity. In the insulin signaling pathway similar regulatory mechanisms impact EEF2’s role in translation.

EEF2 connects to cancer and neurodegenerative diseases. In cancer aberrant regulation of EEF2 can lead to uncontrolled protein synthesis promoting cell proliferation and tumor growth. Its interaction with mTOR and other signaling proteins like ribosomal proteins plays a role in this dysregulation. In neurodegenerative conditions such as Alzheimer’s disease impaired EEF2 activity results in decreased synaptic protein synthesis affecting neuronal function. Understanding EEF2’s regulation and dysregulation provides insight into its involvement in these diseases offering potential for therapeutic intervention.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the GTP-dependent ribosomal translocation step during translation elongation (PubMed : 26593721). During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively (PubMed : 26593721). Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome (PubMed : 26593721).
See full target information EEF2 phospho T56

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com